Introduction
The brain is the most complex organ in the mammalian body. It processes sensory information from our external environment, produces behavior, emotions and memories, and regulates the internal body homeostasis. To fulfill these diverse functions the brain harbors a myriad of neuronal networks processing information and connecting input and output systems. Because of the highly specialized functions, each neuron population is neurochemically specified expressing the necessary sets of proteins. Consequently a large number of genes are expressed in the mammalian brain. Based on microarray and in situ hybridization studies it is estimated that approximately 55-80% of all mouse genes are expressed in the brain [1, 2] (gene expression during developmental stages and pathological conditions not included). Interestingly 70% of these genes are expressed in different cell populations each covering less than 20% of the brain, indicating the complexity of the brain and the specialization of individual populations of neurons [1] .
The success of humans as a species relies on our mental abilities, a result of brain development during evolution. The human brain is distinguished from other mammalian brains by its size; especially the neocortex involved in higher cognitive functions is greatly enlarged in humans. In spite of this difference, the human brain has many similarities to brains of other mammalian species, and to some extent mammalian brains have a well preserved basic architecture (basic uniformity) [for review see, 3, 4] . Therefore, most human brain nuclei and connections have orthologs in other mammalian species ranging from great apes to rodents.
Genetic variation underpins interspecies variation in gene expression and assembly of proteins. The human and rat genomes encode similar numbers of genes, of which majority have persisted throughout evolution without deletion or duplication [5] . It is evident that small changes in protein structure and altered expression levels of proteins influence brain development and form the basis of interspecies differences. However, most human genes have orthologs in rodents, and for most cell types in the brain their neurochemical specification has been preserved throughout evolution. Due to genomic homology, and similarity in basic layout of the mammalian brain, as well as the preservation of neurochemical specification of subsets of neurons throughout evolution, animal models have shown their value in medical neurosciences [6] .
Advances in science are largely dependent on the processing of available information and the generation of new concepts, and are driven by innovation and availability of new technologies. Recently, mRNA based techniques have emerged as an effective tool for genome-wide analysis of expression levels in entire organs or disease-affected tissue.
Results obtained from these studies are a source for identification of 'novel' key molecules and have a predictive value to estimate changes in protein syntheses. There are several ongoing initiatives focusing on the expression profiles of the mammalian brain. The Allen Brain Atlas (www.brainatlas.org) has produced detailed in situ hybridization profiles for over 20 .000 genes in the mouse brain [1] . The GENSAT project (www.gensat.org) uses enhanced green fluorescent protein (EGFP) reporter genes incorporated into BAC transgenic mice to visualize the expression profiles of the most important genes [7] . This strategy can result in the identification of expressing cell types, as the detailed morphology of EGFP-expressing cells is apparent. The Brain Maps project (www.brainmaps.org) has a large collection of mammalian and non-mammalian brain maps, using 'classical' histochemical techniques, but also includes a few protein distribution profiles visualized using immunohistochemistry [8] .
We previously described the possibilities of using antibodies raised against human proteins on rodent brain tissue. [9] Here we show the first efforts to produce detailed proteome wide large scale tissue profiling maps of a mammalian brain using an antibody based proteomic approach. In addition to the available, mentioned information on mRNA levels (Allen Brain Atlas), gene expression profiles (GENSAT), and detailed neuroanatomy (Brain Maps), antibody based proteomics provide new information on cellular and subcellular distribution of gene products. This information will increase general knowledge and understanding of the organization and functioning of the brain. The study is based on antibodies generated as part of the Human Protein Atlas (www.proteinatlas.org) program aimed at exploring the protein expression patterns in normal and cancer tissues using tissue microarray-based immunohistochemistry and fluorescent-based confocal microscopy [10] .
(Figure 1 approximately here)
The Human Proteome Resource center (HPR) aims to produce mono-specific antibodies against every human gene. So far, the distribution profiles of 3,000 proteins in 48 human tissues, including 4 brain areas (cerebellum, cerebral cortex, the hippocampal formation, and lateral subventricular zone), and 20 cancers are available (www.proteinatlas.org). The antibodies generated within the frame-work of this program are based on antigens selected as unique regions for each individual protein, called Protein Epitope Signature Tags (PrEST) [11, 12] . Over 5,000 antibodies have been generated and validated using Western blot analysis and protein arrays [13] . We previously investigated the possibilities to use antibodies generated against human proteins on rat brain tissue [9] . The smaller size of the rat brain allows analysis of many brain areas and exposure of the antibodies to a very wide variety of proteins. Furthermore, tissue can be processed under perfect conditions optimizing tissue antigenicity with flawless tissue morphology.
Here we describe the initial large scale mapping of 89 protein distribution profiles in 25 selected rat brain areas. By exposing systematically sampled rat brain tissue to our collection of mono-specific antibodies a more detailed protein atlas of the mammalian brain is produced, expanding the 4 brain areas available in the human protein atlas to 25 brain areas (Figure 1 
Experimental procedures
All experiments on animals conformed to the European Communities Council Directive (86/609/EEC) and were approved by the local ethical committee (Stockholms Norra Djursförsöksetiska Nämnd; N396/06 N397/06). All performed experimental procedures are previously described in detail [9] .
Colchicine treatment: Rats were anesthetized by an intraperitoneal (i.p.) injection of a cocktail of Hypnorm and Midazolam followed by an intracerebroventricular injection of the mitosis inhibitor colchicine (dissolved in 0.9% NaCl solution to a final concentration of 90 μg in 15 μl). Animals were sacrificed 24 hours after colchicine injection.
Tissue processing: Rats were deeply anesthetized by i.p. injection of pentobarbital (60 mg/kg) and were transcardially perfused with 300 ml fixative composed of 4% paraformaldehyde and 0.2% picric acid in phosphate buffer, which was preceded by a short pre-rinse (50 ml) with calcium-free Tyrode's solution. After dissection, brains were post-fixed for 90 min at 4°C and transferred to 0.01M PB containing 10% sucrose, 0.02% Bacitracin and 0.01% sodium azide for 48 h at 4°C. After dehydration the brains were quickly frozen using CO2. Coronal sections (14 μm) were cut in a cryo-microtome and thaw-mounted on gelatinalum coated slides with a sampling interval of 0.7 mm.
Immunocytochemistry: Specific protein epitope signature tags (PrESTs) of 100-150 amino acids for each target protein were designed using bioinformatics tools [11] and available information on the human genome (Ensembl database). PrESTs were carefully selected, transmembrane regions and signal peptides were avoided, and only amino acid sequences with low homology to other human proteins were used in order to avoid cross-reactivity.
Selected PrESTs were recombinantly produced in Escherichia coli and used to immunize rabbits, and mono-specific polyclonal antibodies were generated through immunoaffinity purification of the resulting antisera [14] . Detailed immunohistochemistry procedures are described elsewhere [9] . Briefly, after a quick rinse in PBS, thaw-mounted sections were incubated for 16-24 h with the rabbit mono-specific antibodies at a standard dilution (1:1,000) followed by 30 min incubation with horseradish peroxidase-conjugated swine anti-rabbit IgG (Dako, P0217, Copenhagen, Denmark). Immunoreactivity was visualized using the tyramide signal amplification system (TSA-Plus, NEL741B001KT, NEN Life Science Products, Inc., Boston, MA). All used HPR antibodies presented in this paper are listed in Table 1 . For double-staining immunohistochemistry, single-staining (as described above) with antibodies against PDZ binding kinase (PBK) (1:1,000; HPA005753) and C6orf64 (1:1,000; HPA007959) was followed by a overnight incubation at 4°C with a Goat anti-doublecortin (DCx) West Grove, PA, USA). The combination of TSA-amplification with direct fluorescence can be used for double labeling experiments using primary antibodies raised in the same species against proteins expressed in different cells or cellular compartments [17] . This method was used to for double-labeling experiments using rabbit antibodies targeted against Ki67 and PBK. All antibodies generated and validated within the Human Protein Atlas project and used in this report will be available for the scientific community and can be purchased via Prestige Antibodies (Sigma-Aldrich, St. Louis, MS, USA) or Atlas Antibodies (Stockholm, Sweden).
( Table 1 approximately here) Imaging: After processing, sections were examined using a Nikon Eclipse E600 fluorescence microscope (Nikon, Tokyo, Japan), equipped with epi-fluorescence with appropriate filter combinations. Photographs were taken using a Hamamatsu ORCA-ER C4742-80 digital camera (Hamamatsu, Hamamatsu city, Japan). Images were acquired using a 10x objective, covering an area of 1,3x1.0 mm with a 1 pixel/m resolution. Scale bars in figure 3 and in the online available micrographs are 100 m. Confocal laser scanning was performed on a BioRad Radiance Plus confocal laser scanning microscope. Digital images were slightly modified to optimize image resolution, brightness and contrast using Adobe Photoshop 10.01 software (Adobe Systems Inc., San Jose, CA), so as to best represent the immunocytochemistry observed in the microscope.
Western blot: Animals were quickly euthanized in CO 2 -rich atmosphere, and samples of the somatosensory cortex, dorsal hippocampal formation (HiFo) and hypothalamus were collected and snap-frozen using dry ice. Samples were homogenized, diluted to a final protein concentration of 2 μg/μl, and denatured. Equal amounts of somatosensory cortex, HiFo and hypothalamus homogenates were mixed, proteins were resolved using SDS-polyacrylamide electrophoreses on 10% gels and transferred to PVDF membrane (Immobilon-FL, Millipore, Bedford, USA). The membranes were probed with the rabbit primary antibodies followed by incubation with IRDye-800 conjugated goat anti-rabbit IgG (Rockland Immunochemicals, Philadelphia, USA). Blotted proteins were detected and analyzed using the Odyssey infrared imaging system (Li-cor, Lincoln, Nebraska, USA). Antibodies that showed a band of expected size or slightly bigger (20% or +10 kDa), presumably due to posttranslational modification, 
Results and Discussion

Protein atlas of the mammalian brain
This investigation involves a pilot study of 800 antibodies selected from the Human Protein Atlas program by the criteria that the antigen used for generation of the affinity reagent showed at least 75% homology with their rat protein orthologs, and that the antibodies did not fail Western blot validation on human cell lines [18] . All 800 antibodies were applied to coronal sections of the rat brain including cortex, the HiFo, thalamus, and hypothalamus. Antibodies that showed clear and selective immunoreactivity were further validated for specificity using Western blot analysis of rat brain homogenates and bio-informatics as described previously [9] . All antibodies that passed validation (12% of all 800 antibodies tested) were applied on coronal sections (14 µm thick, 0.7 mm interval) of a 'normal' and a colchicine-treated rat brain. [19] . Also in the rodent brain HPA antibodies against calretinin (CALB2) and postsynaptic density-95/Discs large/zona occludens-1-binding kinase (PBK) revealed similar staining patterns with equal detail compared to commercial and 'academic' antibodies against these proteins (data not shown). PBK is highly enriched in neural stem cells [20] . Antibody HPA005753 raised against human PBK strongly labeled cells in the subventricular zone and the dentate gyrus of the HiFo, areas known to contain neural progenitors. Doubleimmunohistochemistry with Dcx, an early marker for neurons, and Ki67, a nuclear marker for proliferating cells, revealed limited colocalization of PBK with Dcx ( Figure 5A ). Double-labeling experiments using rabbit antibodies against the nuclear marker Ki67 and cytosolic marker PBK revealed co-existence of both markers in neural progenitors ( Figure 5B-C) . Our PBK antibody shows immunoreactivity of the soma and proximal processes ( Figure 5C ) and gives the possibility to investigate subcellular co-distribution of proteins expressed in these dividing cells.
A further example is calretinin (CALB2), which is related to calbindin-D28k and belongs to the family of calcium binding proteins. Calretinin is expressed throughout the brain in many neuron populations [21] , and calretinin antibodies are often used to label neuronal subpopulations [22] . In the cerebral cortex calretinin is known to be expressed in some 
Colchicine-treated brain
Many proteins are rapidly transported from the cell body into the axon and nerve terminals, and are thus difficult to detect in the cell soma. The mitosis inhibitor colchicine arrests this centrifugal transport and will cause protein accumulation in the soma. In addition, colchicine 
Concluding remarks and future perspectives
Even though many aspects of antibody generation can be controlled and, in fact, are controlled in this project, the actual immunization process is not well characterized.
Immunization with the same protein fragment, or even different bleeds from the same animal, often result in variation in antibody titer affecting sensitivity and specificity of the produced antisera. Therefore validation of specificity has to be implemented, even if antibodies have been affinity purified using the antigen as affinity ligand. Sensitivity of the antibodies will determine the threshold of detection. Structures with high concentrations of target proteins can be visualized, and the quality of the antibodies will determine the level of detail that can be obtained. Therefore absence of staining can be a sensitivity issue, and negative results have to be interpreted with caution. This may be one reason for discrepancies between immunohistochemistry and results obtained with mRNA based techniques. However, also the latter techniques may have sensitivity and specificity problems. Furthermore, translation is regulated, and levels of mRNA do not always resemble actual protein concentrations [26, 27] .
Within the Human Protein Atlas program, antibody generation for 16,000 genes has been initiated, and it has been estimated that a first draft of the human proteome can be achieved by 2015 [28] . We show here that many of these antibodies can be used to explore the rat brain to potentially generate a brain atlas based on immunohistochemistry as a complement to the expression-based atlas programs (see above).
Antibody-based high throughput profiling of human cancers has already resulted in the identification of new biomarkers for different types of cancers [29, 30] Table 1 List of antibodies presented including references to published immunohistochemical data on brain tissue. % is the percentage homology between the PrEST and the corresponding fragment of the rat orthologs. Western blot scores 1) single band of predicted size, 2) Strong band of predicted size, but also other bands of unexpected size, and 3) Band of predicted size, but also strong bands of unexpected size (Figure 2) . The difference between measured protein size and predicted theoretical size. 
